| Literature DB >> 32613085 |
Benjamin W Nelson1,2, Carissa A Low3, Nicholas Jacobson4,5, Patricia Areán6, John Torous7, Nicholas B Allen1.
Abstract
Researchers have increasingly begun to use consumer wearables or wrist-worn smartwatches and fitness monitors for measurement of cardiovascular psychophysiological processes related to mental and physical health outcomes. These devices have strong appeal because they allow for continuous, scalable, unobtrusive, and ecologically valid data collection of cardiac activity in "big data" studies. However, replicability and reproducibility may be hampered moving forward due to the lack of standardization of data collection and processing procedures, and inconsistent reporting of technological factors (e.g., device type, firmware versions, and sampling rate), biobehavioral variables (e.g., body mass index, wrist dominance and circumference), and participant demographic characteristics, such as skin tone, that may influence heart rate measurement. These limitations introduce unnecessary noise into measurement, which can cloud interpretation and generalizability of findings. This paper provides a brief overview of research using commercial wearable devices to measure heart rate, reviews literature on device accuracy, and outlines the challenges that non-standardized reporting pose for the field. We also discuss study design, technological, biobehavioral, and demographic factors that can impact the accuracy of the passive sensing of heart rate measurements, and provide guidelines and corresponding checklist handouts for future study data collection and design, data cleaning and processing, analysis, and reporting that may help ameliorate some of these barriers and inconsistencies in the literature.Entities:
Keywords: Biomarkers; Cardiovascular diseases; Psychology; Risk factors
Year: 2020 PMID: 32613085 PMCID: PMC7320189 DOI: 10.1038/s41746-020-0297-4
Source DB: PubMed Journal: NPJ Digit Med ISSN: 2398-6352
Summary of most popular consumer wearable devices.
| Devicea | Sensor type | FDA status | Sampling rate (i.e., how often it samples) | Sampling frequency | Cost | Market size/share 2019 Q4[ | |||
|---|---|---|---|---|---|---|---|---|---|
| Green LED | Red LED | Infrared LED | ECG | ||||||
| Apple[ | X | X | X | 510(k) class II clearanceb | Variable • Rest—every 10 min • Exercise—continuous | 100 s × per second | $199 (v3) to $399 (v5) | 36.5% | |
| Fitbit[ | X | None | Variable • Rest—5 s intervals • Exercise—1 s intervals | Unknown | $149 (Charge 4) to $199 (Versa 2) | 5.0% | |||
| Garmin[ | X | None | Variable | Variable • High Frequency • Low Frequency | $129 (vivosmart 4) | a | |||
| Samsung | X | None | Manual | Unknown | Galaxy Fit ($99) | 8.8% | |||
| Xiaomi | X | None | Continuous | Unknown | Mi Band 4 ($39.99) | 10.8% | |||
| Huawei[ | X | None | Default is set to manual. Can turn on continuous, which measures every 10 min or every 6–10 s during high-intensity workouts | Unknown | Huawei Band 4 ($42.31) | 7.8% | |||
ECG, electrocardiogram; LED, light-emitting diode.
aData are presented on most recent wearable devices for each manufacturer. Garmin was not included in the top 5, so was listed under other.
bThis only applies to the ECG sensor and high heart rate notifications.
mHealth wearable heart rate metadata checklist 1: descriptive reporting of sample.
| Describe | |
|---|---|
| Study design protocol | |
| Naturalistic or laboratory | □ |
| Group (Psychiatric group diagnostic or symptom selection criteria) | □ |
| Recruitment source | □ |
| Inclusion/exclusion criteria (presence or absence of conditions, age range) | □ |
| Technological factors | |
| Device manufacturer | □ |
| Device type | □ |
| Device version | □ |
| Firmware version | □ |
| Hardware (sensor type) | □ |
| Sampling rate | □ |
| Device reliability and justification for why this level of reliability is adequate for the study design | □ |
| Participant characteristics | |
| Age | □ |
| Race | □ |
| Ethnicity | □ |
| Biological sex | □ |
| Gender | □ |
| Skin tone (e.g., Fitzpatrick skin type) | □ |
| Body mass index | □ |
| Wrist circumference | □ |
| Wrist placement (e.g., dominant or non-dominant) | □ |
| Medical condition | □ |
| Cardioactive medication use | □ |
| Data cleaning, handling, and analysis | |
| Summary bpm metric calculation (e.g., mean, median) | □ |
| For multiple samples per minute, how was final bpm calculated | □ |
| Definition of non-wear-time and reason for data loss (battery life, device failure, participant attrition) | □ |
| Dealing with missing data | □ |
| Listwise deletion (not recommended) | □ |
| Pairwise deletion (not recommended) | □ |
| Model-based (e.g. full-information maximum likelihood, multiple imputation) | □ |
| Outlier identification and correction | □ |
| Wrist circumferenc | □ |
| Wrist placement | □ |
| Dominant or non-dominant | □ |
| Tight vs loose | □ |
| Naturalistic use by participants vs explicit instructions by experimenters | □ |
| Data reporting | |
| Reporting descriptives (e.g., mean, standard deviation, range for overall sample and by group) | □ |
| Data transparency | |
| Preregistration | □ |
| Large passive sensing data sets will be ripe for p-hacking. Pre-register analyses prior to viewing data collected or try to draw predictions from out of sample predictions. | □ |
| Open code and data | □ |
| Provide access to code and data, if applicable | □ |
mHealth wearable heart rate metadata checklist 2: potential covariates.
| Control | |
|---|---|
| Technological factors | |
| Device manufacturer | □ |
| Device type | □ |
| Device version | □ |
| Firmware version | □ |
| Hardware (sensor type) | □ |
| Sampling rate | □ |
| Device reliability and justification for why this level of reliability is adequate for the study design | □ |
| Participant characteristics | |
| Age | □ |
| Race | □ |
| Ethnicity | □ |
| Biological sex | □ |
| Gender | □ |
| Skin tone (e.g., Fitzpatrick skin type) (e.g., Fitzpatrick scale) | □ |
| Body mass index | □ |
| Wrist circumference | □ |
| Wrist placement | □ |
| Dominant or non-dominant | □ |
| Tight vs loose | □ |
| Naturalistic use by participants vs explicit instructions by experimenters | □ |
| Medical condition | □ |
| Cardioactive medication use | □ |